Improving the Evidence for New Interventions in Infectious Diseases: Refocusing on Patients Instead of Pathogens and Direct Evidence for Added Patient Benefits
- PMID: 32337530
- DOI: 10.1093/cid/ciaa463
Improving the Evidence for New Interventions in Infectious Diseases: Refocusing on Patients Instead of Pathogens and Direct Evidence for Added Patient Benefits
Keywords: clinical trials; endpoints; incentives; infectious diseases; value-based care.
Comment on
-
Assessment of Data Supporting the Efficacy of New Antibiotics for Treating Infections Caused by Multidrug-resistant Bacteria.Clin Infect Dis. 2021 Jun 1;72(11):1968-1974. doi: 10.1093/cid/ciaa457. Clin Infect Dis. 2021. PMID: 32337578
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical